Salt la conţinut

Oncologie (Pediatrie)

Rezultate clinice

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (se deschide o fereastră nouă)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Sursă‎: J Clin Oncol 2014;32(27):3021-32.

Index‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (se deschide o fereastră nouă)

Red blood cell transfusion and outcome in cancer. (se deschide o fereastră nouă)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Sursă‎: Transfus Apher Sci 2017;56(3):287-90.

Index‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (se deschide o fereastră nouă)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (se deschide o fereastră nouă)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Sursă‎: Support Care Cancer 2010;18(10):1341-6.

Index‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (se deschide o fereastră nouă)